[Further clinical use of Dl-15-methyl-prostaglandin F2 alpha and testosterone propionate for termination of early pregnancy in outpatient department].
Zhou
Y F
YF
Cheng
L N
LN
Gan
L
L
Xiong
B Y
BY
Jin
Z Y
ZY
Zheng
L M
LM
D000028:Abortion, Induced; D000728:Androgens; D001695:Biology; D002264:Carboxylic Acids; D055598:Chemical Phenomena; D002621:Chemistry; D003267:Contraception; D003274:Contraceptive Devices, Female; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006728:Hormones; D009930:Organic Chemicals; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction; D012102:Reproductive Control Agents; D013739:Testosterone
D000728:Androgens; D002264:Carboxylic Acids; D006728:Hormones; D009930:Organic Chemicals; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012102:Reproductive Control Agents; D013739:Testosterone
Abortion, Induced; Androgens; Barrier Methods; Biology; Carboxylic Acids; Contraception; Contraceptive Methods; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Hormones; Ingredients And Chemicals; Organic Chemicals; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins; Prostaglandins, Synthetic--administraction and dosage; Reproduction; Reproductive Control Agents; Testosterone--administraction and dosage; Vaginal Barrier Methods; Vaginal Sponge